Structure Therapeutics (NASDAQ:GPCR) just reported results for the first quarter of 2024.
- Structure Therapeutics reported earnings per share of -19 cents. This was above the analyst estimate for EPS of -21 cents.
- The company did not report any revenue for the quarter.